Schistosoma japonicum (S. japonicum) is a worldwide spread pathogen which penetrates host skin and then induces several diseases in infected host, such as fibrosis, formation of granulomas, hepatocirrhosis and hepatomegaly. In present study, for the first time, transcriptomic profiles of mouse livers and skins infected by fork-tailed S. japonicum cercaria or non-fork-tailed S. japonicum cercaria were analyzed by using RNA-seq. The present findings demonstrated that transcriptomic landscapes of livers and skins infected by fork-tailed S. japonicum cercaria or non-fork-tailed S. japonicum cercaria were different. S. japonicum has great influence on hepatic metabolic processes. Fork-tailed S. japonicum cercaria upregulated hepatic metabolic processes, while non-fork-tailed S. japonicum cercaria downregulated hepatic metabolic processes. For the metabolism process or the metabolism enzyme expressional change, the pharmacokinetics of host could be changed during S. japonicum infection, regardless the biotypes of S. japonicum cercariae. The changes of infected skins focused on upregulation of immune response. During the S. japonicum skin infection period, fork-tailed S. japonicum cercaria infection induced stronger immune response comparing with that immune response triggered by non-fork-tailed S. japonicum cercaria. The ranscription factor enrichment analysis showed that Irf7, Stat1 and Stat2 could play important roles in gene regulation during fork-tailed S. japonicum cercaria infection.
Objective euDKA is a fatal complication of diabetes, but its symptoms overlap with common symptoms after cardiac surgery and are not easily detected. euDKA associated with SGLT2i was reported, highlighting the importance of recognizing novel hypoglycemic agents for this condition in different populations. Methods We describe the management of a 58-year-old diabetic man who developed severe nonhyperglycemic ketoacidosis after cardiac surgery. A detailed clinical care assessment and management was performed, including dietary history, physical examination, laboratory evaluation of blood ketone bodies, and results of blood gas analysis for metabolic analysis. Results The results showed that the blood ketone body was elevated, accompanied by severe metabolic acidosis and clinical symptoms of polydipsia, polyphagia and polyuria. After massive fluid replacement, small dose insulin treatment, and adjustment of diet structure, the patient's clinical symptoms disappeared, and the blood ketone body laboratory results returned to normal. Conclusions This case highlights the association between non-hyperglycemic diabetic ketoacidosis and sodium-glucose cotransporter 2 inhibitors, and emphasizes the importance of thorough medication history and blood test results for accurate diagnosis. As de novo diabetes agents become more popular worldwide, increased awareness of nonhyperglycemic diabetic ketoacidosis is critical to ensure prompt diagnosis and effective management.